Skip to content
The Nexus
BUSINESSJul 30 · 10:49 UTCWTOP DCWTOP Staff

Regeneron: Q2 Earnings Snapshot

Regeneron Pharmaceuticals Inc. reported second-quarter profit of $1.3 billion with adjusted earnings of $14.29 per share, surpassing Wall Street's expectation of $10 per share. The company also posted revenue of $4.29 billion, exceeding forecasts of $3.84 billion.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Regeneron PharmaceuticalsorganizationTarrytown, New YorkplaceAutomated InsightsorganizationZacks Investment ResearchorganizationREGNorganization
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting